Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Cash flows from operating activities:    
Net loss $ (8,878) $ (18,378)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,622 2,251
Provision for bad debts 480  
Stock-based compensation expense 554 2,571
Deferred income taxes (203) (702)
Unrealized foreign currency transaction gain 1,399 2,354
Other 97 27
Changes in operating assets and liabilities:    
Accounts receivable 5,456 9,100
Unbilled receivables (11,215) (4,957)
Inventory 720 (43)
Prepaid expenses and other current assets and other assets 469 (2,107)
Accounts payable (1,079) 2,401
Accrued expenses and other liabilities 535 (9,153)
Deferred revenue (2,977) (7,060)
Other operating activities   2,424
Net cash used in operating activities (13,020) (21,272)
Cash flows from investing activities:    
Purchases of property and equipment (252) (328)
Cash paid for acquisitions, net (3,838)  
Purchases of marketable securities (852) (8,510)
Proceeds from sales and maturities of marketable securities 3,343 6,649
Net cash used in investing activities (1,599) (2,189)
Cash flows from financing activities:    
Proceeds from issuance of common stock 66 82
Repurchases of common stock (142)  
Other financing activities   (44)
Net cash (used in) provided by financing activities (76) 38
Effect of exchange rate on cash and cash equivalents 265 1,859
Net decrease in cash, cash equivalents and restricted cash (14,430) (21,564)
Cash, cash equivalents and restricted cash at beginning of period 20,317 43,661
Cash, cash equivalents and restricted cash at end of period 5,887 22,097
Supplemental disclosure of cash flow information    
Income taxes paid 454 $ 2,908
Non-cash activities:    
Fair value of common stock issued in acquisition $ 874